232 related articles for article (PubMed ID: 19684083)
1. Direct expansion of human allospecific FoxP3+CD4+ regulatory T cells with allogeneic B cells for therapeutic application.
Chen LC; Delgado JC; Jensen PE; Chen X
J Immunol; 2009 Sep; 183(6):4094-102. PubMed ID: 19684083
[TBL] [Abstract][Full Text] [Related]
2. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells.
Zheng J; Liu Y; Qin G; Chan PL; Mao H; Lam KT; Lewis DB; Lau YL; Tu W
J Immunol; 2009 Sep; 183(6):3742-50. PubMed ID: 19684082
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
4. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells.
Crellin NK; Garcia RV; Levings MK
J Immunol Methods; 2007 Jul; 324(1-2):92-104. PubMed ID: 17582431
[TBL] [Abstract][Full Text] [Related]
6. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.
Pozo D; Anderson P; Gonzalez-Rey E
J Immunol; 2009 Oct; 183(7):4346-59. PubMed ID: 19734220
[TBL] [Abstract][Full Text] [Related]
7. Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody can prevent rat cardiac allograft rejection.
Kitazawa Y; Fujino M; Sakai T; Azuma H; Kimura H; Isaka Y; Takahara S; Hünig T; Abe R; Li XK
J Heart Lung Transplant; 2008 Apr; 27(4):362-71. PubMed ID: 18374871
[TBL] [Abstract][Full Text] [Related]
8. Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy.
Sumida Y; Nakamura K; Kanayama K; Akiho H; Teshima T; Takayanagi R
Cytotherapy; 2008; 10(7):698-710. PubMed ID: 18985477
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy.
Feng G; Wood KJ; Bushell A
Transplantation; 2008 Aug; 86(4):578-89. PubMed ID: 18724229
[TBL] [Abstract][Full Text] [Related]
10. Donor reactive regulatory T cells.
Feng G; Chan T; Wood KJ; Bushell A
Curr Opin Organ Transplant; 2009 Aug; 14(4):432-8. PubMed ID: 19448539
[TBL] [Abstract][Full Text] [Related]
11. Keratinocyte growth factor improves allogeneic bone marrow engraftment through a CD4+Foxp3+ regulatory T cell-dependent mechanism.
Bruinsma M; van Soest PL; Leenen PJ; Löwenberg B; Cornelissen JJ; Braakman E
J Immunol; 2009 Jun; 182(12):7364-9. PubMed ID: 19494258
[TBL] [Abstract][Full Text] [Related]
12. Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD.
Koenecke C; Czeloth N; Bubke A; Schmitz S; Kissenpfennig A; Malissen B; Huehn J; Ganser A; Förster R; Prinz I
Eur J Immunol; 2009 Nov; 39(11):3091-6. PubMed ID: 19750478
[TBL] [Abstract][Full Text] [Related]
13. In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses.
Wu J; Yi S; Ouyang L; Jimenez E; Simond D; Wang W; Wang Y; Hawthorne WJ; O'Connell PJ
Transplantation; 2008 Jun; 85(12):1841-8. PubMed ID: 18580479
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential.
Masteller EL; Tang Q; Bluestone JA
Semin Immunol; 2006 Apr; 18(2):103-10. PubMed ID: 16458533
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells contribute to the immunoregulatory effect on graft versus host reaction after liver transplantation in donor-dominant one-way MHC matching rats.
Xue F; Chen W; Wang X; Wang L; Xu G; Liang L; Bai X; Liang T
Transpl Immunol; 2009 Mar; 20(4):232-7. PubMed ID: 19041396
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease.
Karakhanova S; Munder M; Schneider M; Bonyhadi M; Ho AD; Goerner M
J Immunother; 2006; 29(3):336-49. PubMed ID: 16699377
[TBL] [Abstract][Full Text] [Related]
17. Expanded murine regulatory T cells: analysis of phenotype and function in contact hypersensitivity reactions.
Ring S; Thome M; Pretsch L; Enk AH; Mahnke K
J Immunol Methods; 2007 Sep; 326(1-2):10-21. PubMed ID: 17689553
[TBL] [Abstract][Full Text] [Related]
18. De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid.
Wang J; Huizinga TW; Toes RE
J Immunol; 2009 Sep; 183(6):4119-26. PubMed ID: 19717521
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion.
Miyara M; Wing K; Sakaguchi S
J Allergy Clin Immunol; 2009 Apr; 123(4):749-55; quiz 756-7. PubMed ID: 19348913
[TBL] [Abstract][Full Text] [Related]
20. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
